Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001) Meeting Abstract
| Authors: | Patel, M.; Siena, S.; Demetri, G.; Doebele, R.; Chae, Y.; Conkling, P.; Garrido-Laguna, I.; Longo, F.; Rolfo, C.; Sigal, D.; Drilon, A.; Liu, S.; Goto, K.; Bazhenova, L.; Lonardi, S.; Ciardiello, F.; Huang, X.; Osborne, S.; Aziez, A.; de Braud, F. |
| Abstract Title: | Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001) |
| Meeting Title: | ESMO 22nd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Jul 1-4 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-07-01 |
| Start Page: | S232 |
| End Page: | S233 |
| Language: | English |
| ACCESSION: | WOS:000558722000428 |
| DOI: | 10.1016/j.annonc.2020.04.056 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O-3 -- Source: Wos |
